Cargando…

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients

Circulating MFAP4 is a relevant biomarker to identify COPD patients at risk of death and cardiovascular comorbidity after smoking cessation http://ow.ly/6vnL30o8t1g

Detalles Bibliográficos
Autores principales:	Johansson, Sofie Lock, Wulf-Johansson, Helle, Schlosser, Anders, Titlestad, Ingrid L., Miller, Bruce, Tal-Singer, Ruth, Holmskov, Uffe, Vestbo, Jørgen, Sørensen, Grith Lykke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Original Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469069/ https://www.ncbi.nlm.nih.gov/pubmed/31024964 http://dx.doi.org/10.1183/23120541.00021-2019

Ejemplares similares

Enzyme-Linked Immunosorbent Assay Characterization of Basal Variation and Heritability of Systemic Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2013)

Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions
por: Wulf-Johansson, Helle, et al.
Publicado: (2013)

Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2015)

Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease
por: Lock-Johansson, Sofie, et al.
Publicado: (2014)

Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
por: Mölleken, Christian, et al.
Publicado: (2019)

Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar‐associated protein 4
por: Madsen, Bjørn S., et al.
Publicado: (2020)

Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
por: Sækmose, Susanne Gjørup, et al.
Publicado: (2021)

Microfibrillar-associated protein 4 variation in symptomatic peripheral artery disease
por: Hemstra, Line Ea, et al.
Publicado: (2018)

Surfactant Protein D Deficiency Aggravates Cigarette Smoke-Induced Lung Inflammation by Upregulation of Ceramide Synthesis
por: Pilecki, Bartosz, et al.
Publicado: (2018)

Microfibrillar‐associated protein 4 in serum is associated with asthma in Danish adolescents and young adults
por: Hoffmann‐Petersen, Benjamin, et al.
Publicado: (2019)

Long-term survival for COPD patients receiving noninvasive ventilation for acute respiratory failure
por: Titlestad, Ingrid L, et al.
Publicado: (2013)

Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients
por: Kanaan, Reine, et al.
Publicado: (2023)

Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
por: Langholm, Lasse L, et al.
Publicado: (2020)

A Variant Form of the Human Deleted in Malignant Brain Tumor 1 (DMBT1) Gene Shows Increased Expression in Inflammatory Bowel Diseases and Interacts with Dimeric Trefoil Factor 3 (TFF3)
por: Madsen, Jens, et al.
Publicado: (2013)

The role of microfibrillar‐associated protein 2 in cancer
por: Xu, Wanzhen, et al.
Publicado: (2022)

Are patients with COPD treated with NIV in accordance with national guidelines? An internal audit
por: Titlestad, Ingrid L., et al.
Publicado: (2014)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis
por: Torp, Nikolaj, et al.
Publicado: (2021)

Generation of novel trimeric fragments of human SP-A and SP-D after recombinant soluble expression in E. coli
por: Watson, Alastair, et al.
Publicado: (2020)

Crystal Structure of the Tetrameric Fibrinogen-like Recognition Domain of Fibrinogen C Domain Containing 1 (FIBCD1) Protein
por: Shrive, Annette K., et al.
Publicado: (2014)

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
por: Sivapalan, Pradeesh, et al.
Publicado: (2017)

Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV
por: Watson, Alastair, et al.
Publicado: (2017)

Structural studies of elastic fibre and microfibrillar proteins
por: Singh, Mukti, et al.
Publicado: (2021)

Declined plasma microfibrillar-associated protein 4 levels in acute coronary syndrome
por: Han, Chunming, et al.
Publicado: (2023)

Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D
por: Hartshorn, Kevan L, et al.
Publicado: (2007)

FIBCD1 Binds Aspergillus fumigatus and Regulates Lung Epithelial Response to Cell Wall Components
por: Jepsen, Christine Schoeler, et al.
Publicado: (2018)

Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients
por: Bracht, Thilo, et al.
Publicado: (2016)

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD – results from the ECLIPSE study
por: Sand, Jannie M. B., et al.
Publicado: (2016)

Internet access and use by COPD patients in the National Emphysema/COPD Association Survey
por: Martinez, Carlos H, et al.
Publicado: (2014)

Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

THE MICROFIBRILLAR STRUCTURE OF THE CELL WALLS OF THE FILAMENTOUS FUNGUS, Allomyces
por: Aronson, Jerome M., et al.
Publicado: (1960)

Microfibrillar Polysaccharide-Derived Biochars as Sodium Benzoate Adsorbents
por: Liu, Dagang, et al.
Publicado: (2017)

Essential role of microfibrillar-associated protein 4 in human cutaneous homeostasis and in its photoprotection
por: Kasamatsu, Shinya, et al.
Publicado: (2011)

Microfibrillar-associated protein 2 is a prognostic marker that correlates with the immune microenvironment in glioma
por: Xu, Wanzhen, et al.
Publicado: (2022)

Microfibrillar-associated protein 5 suppresses adipogenesis by inhibiting essential coactivator of PPARγ
por: Zhang, Tianlong, et al.
Publicado: (2023)

Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values
por: AKIKI, ZEINA, et al.
Publicado: (2016)

Peptidoglycan Recognition Peptide 2 Aggravates Weight Loss in a Murine Model of Chemotherapy-Induced Gastrointestinal Toxicity
por: Bech, Ann-Sophie, et al.
Publicado: (2021)

Upregulation of microfibrillar-associated protein 2 is closely associated with tumor angiogenesis and poor prognosis in hepatocellular carcinoma
por: Zhang, Nu, et al.
Publicado: (2021)

Association Between Air Pollution and Lung Lobar Emphysema in COPD
por: Tung, Nguyen Thanh, et al.
Publicado: (2021)

COPD/emphysema: The vascular story
por: Voelkel, Norbert F., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dv1jvgv3n5u23cq4145i4pprb3